Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04087980 · ClinicalTrials.gov registry record · NA

Ablation of Prostate Tissue Utilizing Sterile Water Vapor in Patients With Intermediate Risk Localized Prostate Cancer

A NA study of Prostate Cancer, sponsored by Francis Medical.

Completed
Registry status
NA
Development phase
26
Enrollment target
5
Study locations

NCT04087980 is a NA study of Prostate Cancer that has completed, run by Francis Medical. The registered enrollment target is 26 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (96% lower). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04087980, a NA study of Prostate Cancer, has completed, sponsored by Francis Medical.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this research study is to collect information on a new treatment of prostate tissue participants with intermediate risk prostate cancer using a medical device called the Poseidon System. The Poseidon System is intended to ablate prostate tissue in areas of the prostate where cancer has been identified. The medical device delivers thermal energy in the form of water vapor to the prostate tissue through the urethra. Previous research has shown successful prostate tissue ablation. Additional research may help show successful ablation of the prostate tissue where cancer is located.

Conditions Studied

Interventions

  • DEVICE Poseidon System

Study Locations (5)

Minnesota

  • University of Minnesota - Minneapolis
  • Minnesota Urology - Woodbury

Maryland

  • Chesapeake Urology - Baltimore

New York

  • Bon Secours/Good Samaritan Hospital - New York

Texas

  • Urology San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2020-04-10
Est. Completion 2022-05-25
Phase NA

Sponsor

Francis Medical

3 total trials

What the Registry Record Tells You About NCT04087980

The ClinicalTrials.gov registry entry for NCT04087980 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Francis Medical, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Poseidon System is the first listed.

NCT04087980 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Minnesota, Maryland, New York.

Frequently Asked Questions

What is clinical trial NCT04087980 about?

NCT04087980 is a clinical study titled "Ablation of Prostate Tissue Utilizing Sterile Water Vapor in Patients With Intermediate Risk Localized Prostate Cancer". The purpose of this research study is to collect information on a new treatment of prostate tissue participants with intermediate risk prostate cancer using a medical device called the Poseidon System. The Poseidon System is intended to ablate prostate tissue in areas of the prostate where cancer ha...

What is the current status of trial NCT04087980?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2020-04-10. Estimated completion is 2022-05-25.

What conditions does trial NCT04087980 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT04087980?

The interventions under investigation include: Poseidon System (DEVICE).

Who is sponsoring clinical trial NCT04087980?

This trial is sponsored by Francis Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04087980 being conducted?

This trial has 5 study locations across Maryland, Minnesota, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.